ALUVIA TABLETS

Aluvia Tablets Adverse Events Reported to the FDA Over Time

How are Aluvia Tablets adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Aluvia Tablets, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Aluvia Tablets is flagged as the suspect drug causing the adverse event.

Most Common Aluvia Tablets Adverse Events Reported to the FDA

What are the most common Aluvia Tablets adverse events reported to the FDA?

Neutropenia	45 (7.63%)
Vomiting	21 (3.56%)
Intra-uterine Death	19 (3.22%)
Pyrexia	18 (3.05%)
Death	16 (2.71%)
Diarrhoea	15 (2.54%)
Jaundice	14 (2.37%)
Abortion Spontaneous	11 (1.86%)
Headache	11 (1.86%)
Drug Exposure During Pregnancy	9 (1.53%)
Malaria	9 (1.53%)
	Show More
Thrombocytopenia	9 (1.53%)
Hypersensitivity	8 (1.36%)
Abdominal Pain	7 (1.19%)
Abortion Incomplete	7 (1.19%)
Anaemia	7 (1.19%)
Asthenia	7 (1.19%)
Cachexia	6 (1.02%)
Dehydration	6 (1.02%)
Nausea	6 (1.02%)
Stillbirth	6 (1.02%)
Ascites	5 (.85%)
Oral Candidiasis	5 (.85%)
Sepsis	5 (.85%)
Anoxia	4 (.68%)
Bacterial Sepsis	4 (.68%)
Bronchopneumonia	4 (.68%)
Convulsion	4 (.68%)
Fracture	4 (.68%)
Hepatitis	4 (.68%)
Hot Flush	4 (.68%)
Hypoglycaemia	4 (.68%)
Liver Disorder	4 (.68%)
Meningism	4 (.68%)
Paraesthesia	4 (.68%)
Premature Baby	4 (.68%)
Rash Generalised	4 (.68%)
Rash Pruritic	4 (.68%)
Trisomy 21	4 (.68%)
Vaginal Haemorrhage	4 (.68%)
Abdominal Distension	3 (.51%)
Colitis	3 (.51%)
Dizziness	3 (.51%)
Drug Interaction	3 (.51%)
Dyspnoea	3 (.51%)
Gastritis	3 (.51%)
Gastroenteritis	3 (.51%)
Hepatic Enzyme Increased	3 (.51%)
Hepatic Failure	3 (.51%)
Hepatitis B	3 (.51%)
Hyponatraemia	3 (.51%)
Ill-defined Disorder	3 (.51%)
Loss Of Consciousness	3 (.51%)
Malaise	3 (.51%)
Myalgia	3 (.51%)
Oesophageal Candidiasis	3 (.51%)
Palpitations	3 (.51%)
Peritonitis	3 (.51%)
Pneumonia Bacterial	3 (.51%)
Premature Rupture Of Membranes	3 (.51%)
Rash Papular	3 (.51%)
Renal Disorder	3 (.51%)
Retinal Detachment	3 (.51%)
Skin Exfoliation	3 (.51%)
Tachycardia	3 (.51%)
Tuberculosis	3 (.51%)
Vision Blurred	3 (.51%)
Weight Decreased	3 (.51%)
Abortion Induced	2 (.34%)
Acquired Immunodeficiency Syndrome	2 (.34%)
Acute Respiratory Failure	2 (.34%)
Altered State Of Consciousness	2 (.34%)
Bacterial Infection	2 (.34%)
Bacterial Toxaemia	2 (.34%)
Blindness	2 (.34%)
Blood Albumin Decreased	2 (.34%)
Blood Creatinine Increased	2 (.34%)
Bone Pain	2 (.34%)
Cd4 Lymphocytes Decreased	2 (.34%)
Chest Pain	2 (.34%)
Completed Suicide	2 (.34%)
Cystitis	2 (.34%)
Decreased Appetite	2 (.34%)
Drug Dispensing Error	2 (.34%)
Drug Intolerance	2 (.34%)
Drug Level Decreased	2 (.34%)
Drug Prescribing Error	2 (.34%)
Dysuria	2 (.34%)
Electrolyte Imbalance	2 (.34%)
Faecaloma	2 (.34%)
Fatigue	2 (.34%)
Gene Mutation	2 (.34%)
Hemiparesis	2 (.34%)
Hypokalaemia	2 (.34%)
Hypoproteinaemia	2 (.34%)
Hypotension	2 (.34%)
Incorrect Dose Administered	2 (.34%)
Listless	2 (.34%)
Malnutrition	2 (.34%)
Maternal Drugs Affecting Foetus	2 (.34%)
Meningitis Cryptococcal	2 (.34%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Aluvia Tablets, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Aluvia Tablets is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Aluvia Tablets

What are the most common Aluvia Tablets adverse events reported to the FDA?

White Blood Cell	45 (7.63%)
Abortions And Stillbirth	43 (7.29%)
Gastrointestinal Signs	42 (7.12%)
Hepatic And Hepatobiliary	26 (4.41%)
Infections - Pathogen Unspecified	25 (4.24%)
Epidermal And Dermal Conditions	21 (3.56%)
Neurological	20 (3.39%)
Body Temperature Conditions	18 (3.05%)
Fatal Outcomes	17 (2.88%)
Gastrointestinal Motility And Defec...	15 (2.54%)
Electrolyte And Fluid Balance Condi...	13 (2.2%)
	Show More
Fungal Infectious	12 (2.03%)
Protozoal Infectious	12 (2.03%)
Chemical Injury And Poisoning	11 (1.86%)
Headaches	11 (1.86%)
Appetite And General Nutritional	10 (1.69%)
Platelet	10 (1.69%)
Respiratory	10 (1.69%)
Allergic Conditions	9 (1.53%)
Anemias Nonhemolytic And Marrow Dep...	8 (1.36%)
Oral Soft Tissue Conditions	8 (1.36%)
Peritoneal And Retroperitoneal Cond...	8 (1.36%)
Bacterial Infectious	7 (1.19%)
Urinary Tract Signs	7 (1.19%)
Chromosomal Abnormalities And Abnor...	6 (1.02%)
Gastrointestinal Inflammatory Condi...	6 (1.02%)
Glucose Metabolism Disorders	6 (1.02%)
Medication Errors	6 (1.02%)
Renal Disorders	6 (1.02%)
Vascular	6 (1.02%)
Viral Infectious	6 (1.02%)
Mycobacterial Infectious	5 (.85%)
Therapeutic And Nontherapeutic Effe...	5 (.85%)
Vision	5 (.85%)
Bone And Joint Injuries	4 (.68%)
Cardiac Arrhythmias	4 (.68%)
Hepatobiliary	4 (.68%)
Maternal Complications Of Labour An...	4 (.68%)
Musculoskeletal And Connective Tiss...	4 (.68%)
Neonatal And Perinatal Conditions	4 (.68%)
Physical Examination Topics	4 (.68%)
Seizures	4 (.68%)
Vulvovaginal Disorders	4 (.68%)
Cardiac Disorder Signs	3 (.51%)
Decreased And Nonspecific Blood Pre...	3 (.51%)
Maternal Complications Of Pregnancy	3 (.51%)
Muscle	3 (.51%)
Ocular Structural Change, Deposit A...	3 (.51%)
Bone Disorders	2 (.34%)
Eye	2 (.34%)
Hematology Investigations	2 (.34%)
Inner Ear And Viiith Cranial Nerve	2 (.34%)
Lower Respiratory Tract Disorders	2 (.34%)
Mood Disorders	2 (.34%)
Movement Disorders	2 (.34%)
Obstetric And Gynecological Therape...	2 (.34%)
Ocular Sensory Symptoms	2 (.34%)
Pregnancy, Labour, Delivery And Pos...	2 (.34%)
Protein And Amino Acid Metabolism	2 (.34%)
Protein And Chemistry Analyses	2 (.34%)
Renal And Urinary Tract Investigati...	2 (.34%)
Suicidal And Self-injurious Behavio...	2 (.34%)
Toxicology And Therapeutic Drug Mon...	2 (.34%)
Angiedema And Urticaria	1 (.17%)
Anterior Eye Structural Change, Dep...	1 (.17%)
Breast	1 (.17%)
Cardiac And Vascular Investigations	1 (.17%)
Deliria	1 (.17%)
Encephalopathies	1 (.17%)
Gastrointestinal Hemorrhages	1 (.17%)
Gastrointestinal Vascular Condition...	1 (.17%)
Heart Failures	1 (.17%)
Injuries	1 (.17%)
Lifestyle Issues	1 (.17%)
Neonatal Respiratory	1 (.17%)
Nephropathies	1 (.17%)
Ocular Infections, Irritations And ...	1 (.17%)
Peripheral Neuropathies	1 (.17%)
Reproductive Tract	1 (.17%)
Skin And Subcutaneous Tissue	1 (.17%)
Skin Appendage Conditions	1 (.17%)
Vascular Hypertensive	1 (.17%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Aluvia Tablets, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Aluvia Tablets is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.